{"schema_version":"1","generated_at":"2026-10-31T13:57:31.298Z","data_as_of":"2026-10-21","url":"https://www.findmykol.com/kol/nitin-ohri","json_url":"https://www.findmykol.com/kol/nitin-ohri/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"nitin-ohri","name":"Nitin Ohri","credential":"MD","title":"Professor, Radiation Oncology","specialty":"Therapeutic Radiology","specialty_raw":"Therapeutic Radiology","therapeutic_area":"Lung","therapeutic_areas":["Lung","Head & Neck","Gastrointestinal"],"institution":"Montefiore Einstein","institution_url":"https://www.findmykol.com/institution/montefiore-einstein","city":"Philadelphia","state":"PA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1346499431","orcid":"0000-0001-9593-513X","openalex":"A5054172281"},"summary":"Nitin Ohri is Professor, Radiation Oncology at Montefiore Einstein. OpenAlex indexes 304 publications with 5,057 citations (h-index 37); ClinicalTrials.gov lists 15 registered studies with this person as an investigator.","overview":{"text":"Nitin Ohri, MD, is Professor, Radiation Oncology at Montefiore Einstein (Albert Einstein College of Medicine). The public record shows 304 publications with 5,057 citations (h-index 37), centered on Lung Cancer Diagnosis and Treatment, Advanced Radiotherapy Techniques, Head and Neck Cancer Studies. It also documents an investigator role on 15 registered clinical trials, industry payments reported by 6 companies.","bullets":["Most recent indexed publication: 2025 · Cancers","Top research focus: Lung Cancer Diagnosis and Treatment","15 registered trials on ClinicalTrials.gov","Open Payments reporting from 6 companies"],"generated_at":"2026-10-30"},"focus":{"indications":[{"label":"Lung Cancer (NSCLC/SCLC)","therapeutic_area":"Oncology","trials":11,"topics":1,"strength":34},{"label":"Small Cell Lung Carcinoma","therapeutic_area":"Oncology","trials":7,"topics":0,"strength":21},{"label":"Head & Neck Cancer","therapeutic_area":"Oncology","trials":2,"topics":1,"strength":7},{"label":"Carcinoma, Small Cell","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Hepatobiliary Cancer","therapeutic_area":"Oncology","trials":1,"topics":1,"strength":4},{"label":"Ovarian / Gynecologic Cancer","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Brain Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Uterine Cervical Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Intestinal Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Gastrointestinal Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Pancreatic Cancer","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3}],"research_topics":["Lung Cancer Diagnosis and Treatment","Advanced Radiotherapy Techniques","Head and Neck Cancer Studies","Hepatocellular Carcinoma Treatment and Prognosis","Cancer survivorship and care"],"drugs_studied":{"total":7,"shown":3,"withheld":4,"rows":[{"name":"Libtayo","generic":"Cemiplimab","trials":0,"payments":6,"publications":0,"mentions":6},{"name":"Imfinzi","generic":"Durvalumab","trials":0,"payments":3,"publications":0,"mentions":3},{"name":"Keytruda","generic":"Pembrolizumab","trials":0,"payments":2,"publications":0,"mentions":2}]},"works_with":{"total":12,"shown":3,"withheld":9,"rows":[{"name":"Montefiore Medical Center","trials":7,"payments":0,"mentions":7},{"name":"Regeneron Pharmaceuticals, Inc.","trials":0,"payments":6,"mentions":6},{"name":"AstraZeneca Pharmaceuticals LP","trials":0,"payments":5,"mentions":5}]}},"scholarship":{"works_count":304,"cited_by_count":5057,"h_index":37,"i10_index":82,"pubmed_count":3,"latest_activity_year":2025,"source":"works"},"trials":{"count":15,"shown":3,"withheld":12,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT07293247","title":"A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment","phase":"PHASE2","status":"RECRUITING","role":"Investigator","sponsor":"Alliance for Clinical Trials in Oncology","source_url":"https://clinicaltrials.gov/study/NCT07293247","trial_url":"https://www.findmykol.com/trial/NCT07293247"},{"nct":"NCT07146230","title":"The Selective Personalized Radio-Immunotherapy for Locally Advanced Non-Small Cell Lung Cancer Trial 2","phase":"PHASE2","status":"NOT_YET_RECRUITING","role":"Investigator","sponsor":"Montefiore Medical Center","source_url":"https://clinicaltrials.gov/study/NCT07146230","trial_url":"https://www.findmykol.com/trial/NCT07146230"},{"nct":"NCT06865339","title":"Thoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung Cancer","phase":"PHASE2","status":"RECRUITING","role":"Investigator","sponsor":"Montefiore Medical Center","source_url":"https://clinicaltrials.gov/study/NCT06865339","trial_url":"https://www.findmykol.com/trial/NCT06865339"}],"source":"trials"},"payments":{"company_count":6,"program_years":{"first":2021,"last":2025},"rows_total":10,"shown":3,"withheld":7,"rows":[{"payer":"Novocure Inc.","program_year":2025,"amount_usd":21.37,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1346499431"},{"payer":"Regeneron Pharmaceuticals, Inc.","program_year":2024,"amount_usd":6258,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1346499431"},{"payer":"Merck Sharp & Dohme LLC","program_year":2024,"amount_usd":2135,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1346499431"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1346499431","source":"payments"},"funding":{"award_count":0,"rows_total":7,"shown":3,"withheld":4,"rows":[{"project":"UG1CA189859","title":"Montefiore Academic Community NCORP Program","fiscal_year":2026,"amount_usd":854906,"organization":"MONTEFIORE MEDICAL CENTER (BRONX, NY)","source_url":"https://reporter.nih.gov/quickSearch/UG1CA189859"},{"project":"P30CA013330","title":"Protocol Review and Monitoring System","fiscal_year":2026,"amount_usd":136762,"organization":"ALBERT EINSTEIN COLLEGE OF MEDICINE","source_url":"https://reporter.nih.gov/quickSearch/P30CA013330"},{"project":"P30CA013330","title":"Protocol Review and Monitoring System","fiscal_year":2025,"amount_usd":136762,"organization":"ALBERT EINSTEIN COLLEGE OF MEDICINE","source_url":"https://reporter.nih.gov/quickSearch/P30CA013330"}],"source":"grants"},"congress":{"count":112,"years":{"first":2009,"last":2026},"societies":["AACR","ASCO","ASTRO"],"shown":3,"withheld":109,"rows":[{"title":"Impact of earlier time of first cycle immunotherapy administration on progression-free survival in real-world metastatic non–small cell lung cancer.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2026.44.16_suppl.e20579","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.e20579","status":"verified"},{"title":"Real-world impact of first immunotherapy infusion timing on outcomes in locally advanced non-small cell lung cancer.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2026.44.16_suppl.8071","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.8071","status":"verified"},{"title":"Real-world outcomes and immune and cardiopulmonary toxicities of durvalumab following concurrent chemoradiotherapy in non–small cell lung cancer.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2026.44.16_suppl.e20097","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.e20097","status":"verified"}],"source":"congress"},"publications":{"total":3,"shown":3,"withheld":0,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Chemotherapy-Free Treatment with Radiotherapy and Immunotherapy for Locally Advanced Non-Small Cell Lung Cancer.","year":2025,"journal":"Cancers","types":["Journal Article","Review"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/40361451/","status":"verified"},{"title":"Selective Personalized RadioImmunotherapy for Locally Advanced Non-Small-Cell Lung Cancer Trial (SPRINT).","year":2024,"journal":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","types":["Journal Article","Research Support, Non-U.S. Gov't"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/37988638/","status":"verified"},{"title":"Remote Activity Monitoring and Electronic Patient-Reported Outcomes Collection During Radiotherapy for Head and Neck Cancer: A Pilot Study.","year":2023,"journal":"JCO clinical cancer informatics","types":["Journal Article","Research Support, N.I.H., Extramural","Research Support, Non-U.S. Gov't"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/37071027/","status":"verified"}],"most_cited":{"total":304,"shown":5,"withheld":299,"rows":[{"title":"Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System","year":2020,"cited_by_count":765,"type":"article","source_url":"https://doi.org/10.1158/2159-8290.cd-20-0516"},{"title":"Radiotherapy Protocol Deviations and Clinical Outcomes: A Meta-analysis of Cooperative Group Clinical Trials","year":2013,"cited_by_count":317,"type":"review","source_url":"https://doi.org/10.1093/jnci/djt001"},{"title":"Local Control After Stereotactic Body Radiation Therapy for Liver Tumors","year":2018,"cited_by_count":231,"type":"article","source_url":"https://doi.org/10.1016/j.ijrobp.2017.12.288"},{"title":"What Is the Best Way to Contour Lung Tumors on PET Scans? Multiobserver Validation of a Gradient-Based Method Using a NSCLC Digital PET Phantom","year":2011,"cited_by_count":214,"type":"article","source_url":"https://doi.org/10.1016/j.ijrobp.2010.12.055"},{"title":"Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19","year":2021,"cited_by_count":192,"type":"article","source_url":"https://doi.org/10.1001/jamaoncol.2021.1799"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Shalom Kalnicki","coauthored_works":104,"profile_url":"https://www.findmykol.com/kol/shalom-kalnicki"},{"name":"Rafi Kabarriti","coauthored_works":88,"profile_url":"https://www.findmykol.com/kol/rafi-kabarriti"},{"name":"Chandan Guha","coauthored_works":72,"profile_url":"https://www.findmykol.com/kol/chandan-guha"}],"source":"works"},"presence":{"owned_accounts":{"total":1,"shown":1,"rows":[{"platform":"doximity","url":"https://www.doximity.com/pub/nitin-ohri-md","status":"provisional"}]},"mentions":{"total":1,"shown":1,"rows":[{"url":"https://doctors.montefioreeinstein.org/providers/1346499431/nitin-ohri","platform":"other","status":"provisional"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":3,"shown":3,"rows":[{"value":"MS, Clinical Research Training Program, Montefiore Einstein (2015)","source_url":"https://doctors.montefioreeinstein.org/providers/1346499431/nitin-ohri","status":"verified","collected_at":"2026-10-30"},{"value":"MD, Washington University (2007)","source_url":"https://doctors.montefioreeinstein.org/providers/1346499431/nitin-ohri","status":"verified","collected_at":"2026-10-30"},{"value":"Board certified in Radiation Oncology, American Board of Radiology","source_url":"https://doctors.montefioreeinstein.org/providers/1346499431/nitin-ohri","status":"verified","collected_at":"2026-10-30"}]},"roles":{"total":3,"shown":3,"rows":[{"value":"Member, American Society for Therapeutic Radiology and Oncology","source_url":"https://doctors.montefioreeinstein.org/providers/1346499431/nitin-ohri","status":"verified","collected_at":"2026-10-30"},{"value":"Member, American Society for Clinical Oncology","source_url":"https://doctors.montefioreeinstein.org/providers/1346499431/nitin-ohri","status":"verified","collected_at":"2026-10-30"},{"value":"Member, American Association for Cancer Research","source_url":"https://doctors.montefioreeinstein.org/providers/1346499431/nitin-ohri","status":"verified","collected_at":"2026-10-30"}]},"awards":{"total":4,"shown":3,"rows":[{"value":"Winner, ASTRO-AstraZeneca Small Cell Lung Cancer (SCLC) Therapy Challenge (2025)","source_url":"https://highlights.montefioreeinstein.org/cancer-center/nitin-ohri-named-winner-astro-astrazeneca-sclc-therapy-challenge","status":"verified","collected_at":"2026-10-30"},{"value":"Outstanding Reviewer Award, International Journal of Radiation Oncology, Biology, Physics","source_url":"https://doctors.montefioreeinstein.org/providers/1346499431/nitin-ohri","status":"verified","collected_at":"2026-10-30"},{"value":"Cancer Care Delivery Research Pilot Project Award, NRG Oncology","source_url":"https://doctors.montefioreeinstein.org/providers/1346499431/nitin-ohri","status":"verified","collected_at":"2026-10-30"}]},"secondary_affiliations":{"total":1,"shown":1,"rows":[{"value":"Radiology (listed as 'Radiation Oncologist, Radiology')","source_url":"https://doctors.montefioreeinstein.org/providers/1346499431/nitin-ohri","status":"verified","collected_at":"2026-10-30"}]},"media":{"total":3,"shown":3,"rows":[{"value":"Applied Radiation Oncology interview on wearable devices in cancer care","source_url":"https://appliedradiationoncology.com/articles/beyond-measure-remote-patient-monitoring-with-wearables","status":"provisional","collected_at":"2026-10-30"},{"value":"Institute of Trials and News (ITN) coverage of step-count study in locally advanced NSCLC, quoting Ohri","source_url":"https://www.itnonline.com/content/study-find-patient-step-counts-predict-lung-cancer-treatment-outcomes","status":"provisional","collected_at":"2026-10-30"},{"value":"OncLive feature on wearable devices in cancer care, quoting Ohri","source_url":"https://onclive.com/view/a-gut-check-on-the-digital-divide-how-wearable-devices-are-changing-cancer-care","status":"provisional","collected_at":"2026-10-30"}]}},"similar":[{"name":"Beth McLellan","slug":"beth-mclellan","institution":"Montefiore Einstein","specialty":"Dermatology","url":"https://www.findmykol.com/kol/beth-mclellan","json_url":"https://www.findmykol.com/kol/beth-mclellan/profile.json"},{"name":"Pasi Janne","slug":"pasi-janne","institution":"Dana-Farber Cancer Institute","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/pasi-janne","json_url":"https://www.findmykol.com/kol/pasi-janne/profile.json"},{"name":"Julie Brahmer","slug":"julie-brahmer","institution":"Johns Hopkins University School of Medicine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/julie-brahmer","json_url":"https://www.findmykol.com/kol/julie-brahmer/profile.json"},{"name":"Enriqueta Felip","slug":"enriqueta-felip","institution":"Vall d'Hebron Institute of Oncology (VHIO)","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/enriqueta-felip","json_url":"https://www.findmykol.com/kol/enriqueta-felip/profile.json"},{"name":"Funda Meric-Bernstam","slug":"funda-meric-bernstam","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Surgery","url":"https://www.findmykol.com/kol/funda-meric-bernstam","json_url":"https://www.findmykol.com/kol/funda-meric-bernstam/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":12,"payments":7,"funding":4,"congress":109,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-10-30"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-10-30"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 to 2025","collected_at":"2026-10-30"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-10-30"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-10-30"}},"methodology_url":"https://www.findmykol.com/about#methodology"}